VEROVACCiNES secures a 7-digit financing to expand its vaccine pipeline

Vaccine specialist secures financing of 1.6 million euros

27-Feb-2025
Computer-generated image

Symbolbild

The veterinary vaccine developer VEROVACCiNES announces the successful comple tion of a €1.6 million  financing round. The round was largely supported by existing investors as well as the founders. This underlines the joint confidence in the innovative strength and strategic direction of the company.

Following the rapid development of a highly efficacious vaccine against bluetongue virus type 3, VEROVACCiNES plans to use the funds raised specifically for the further expansion of its own product pipeline. The company will use its proprietary vaccine technology (Unified Vaccine Platform), which provides ONE coherent system for the generation, development, and production of innovative subunit vaccines along the entire value chain.

“The massive progress we have made over the past year in expanding our technology platform enables us to push ahead with the development of vaccines for our own pipeline and to launch further collaborations,” says Dr. Hanjo Hennemann, CEO of VEROVACCiNES. ”We are grateful to our investors for their support, which allows us to realize our ambitious development goals.”

The CSO of VEROVACCiNES, Prof. Sven-Erik Behrens, emphasizes the importance of the financing round: “With these funds, we can significantly accelerate our vaccine development and bring promising vaccine candidates to the next stage. Our goal is to bring innovative and efficacious vaccines to the market to meet the increasing challenges in animal health long term.”

The investor consortium, consisting of renowned investors from various European countries, is counting on VEROVACCiNES' potential to further revolutionize biotechnological vaccine development and to efficiently develop innovative products with high unique selling points.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Something is happening in the life science industry ...

This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.